drugset / Trial / NCT05201092

A Study Investigating Lu AG06466 in Healthy Men

NCT05201092

Phase 1 Completed 6 enrolled H. Lundbeck A/S
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate how the drug Lu AG06466 is absorbed, metabolized, and excreted from the body, for example, what the body does to the drug after swallowing a single dose.

Timeline

Start
2022-01-05
Primary completion
2022-02-19
Completion
2022-02-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG06466 Unknown Oral

Indications

No indication recorded.